How our Clinical Academic Groups are tackling some of the biggest health issues in our community today.
“Using improved medications, like Tenecteplase, with telehealth and stroke-ready ambulances will mean more Australians will receive urgent pre-hospital care within the precious treatment window where we can really make a difference.” - Professor Mark Parsons
‘A World Turned Topsy Turvy’: Maridulu Budyari Gumal - SPHERE CCI&KT Platform Uses Art to Communicate COVID-19 Experiences
The 'Topsy Turvy' exhibition – created through a unique collaboration with SPHERE Council members and the SPHERE CCI&KT Strategic Platform – uses art to document, share, and generate new insights into COVID-19 experiences.
I am delighted to announce that Professor Mark Parsons has been appointed as the Executive Director, Maridulu Budyari Gumal - Sydney Partnership for Health Education, Research and Enterprise (SPHERE). He commenced in the role on 1 July 2021.
The NSW Government through the Cancer Institute NSW has awarded SPHERE's Professor Geoff Delaney a $7M Translational Cancer Research Capacity Building Grant to build capacity and education across the SPHERE Cancer Clinical Academic Group. Commencing on 1 July, the 5 year program will enhance the volume of cancer research the CAG produces, but also to accelerate research translation; ensure succession planning by enhancing career development opportunities; and continue to stimulate high-quality, multidisciplinary, multi-institutional, innovative, impactful research.
Female researchers from across Australia working in women’s health research and translation have been provided financial support in a bid to facilitate the career advancement and development of women in early and mid-career stages of their research careers.
The podcasts of our chats with members of the Cardiac and Vascular Health, Age and Ageing, and Maternal, Newborn and Women's Clinical Academic Groups.